KVUE — Kenvue Inc. — Income statement

From the XBRL facts of the company's SEC filings. USD, millions, except per-share figures. Latest filing read: 2026-10-30.

No longer files reports with the SEC since 2026-11-12 (Form 15-12G). The statement ends with its last report.

Annual · Quarterly   |   Latest filing · As first reported   |   Download all statements (Excel)

Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025 TTM Sep 2026
Revenues 14,467.0 15,054.0 14,950.0 15,444.0 15,455.0 15,124.0 15,530.0‡
Total revenues 14,467.0 15,054.0 14,950.0 15,444.0 15,455.0 15,124.0 15,530.0‡
Cost of revenues 6,619.0 6,635.0 6,665.0 6,801.0 6,496.0 6,332.0 6,476.0‡
Gross profit 7,848.0 8,419.0 8,285.0 8,643.0 8,959.0 8,792.0 9,054.0‡
Selling, general and administrative 4,956.0 5,484.0 5,633.0 6,141.0 6,329.0 6,088.0 6,094.0‡
Other operating expenses, total 3,871.0‡ 15.0‡ (23.0)‡ (10.0)‡ 789.0‡ 290.0‡ 253.0‡
Operating income (GAAP, as reported) (979.0) 2,920.0 2,675.0 2,512.0 1,841.0 2,414.0 2,707.0‡
Operating income excl. unusual items (S&P method) (979.0)‡ 2,920.0‡ 2,687.0‡ 2,512.0‡ 2,604.0‡ 2,727.0‡ -
Interest expense - 0.0 0.0 250.0 - - -
Net interest expenses - 0.0‡ 0.0 (250.0) (378.0) (379.0) (372.0)‡
Other non-operating income (expenses) (37.0)‡ 5.0‡ 38.0 72.0 48.0 36.0 26.0‡
Other items, reconciling to EBT - - (76.0)‡ (144.0)‡ (96.0)‡ (72.0)‡ (55.0)‡
Asset writedown - - 12.0‡ 0.0‡ 578.0‡ 23.0‡ 23.0‡
Gain (loss) on sale of investments - - 1.0 (7.0) (72.0) 0.0 -
Total unusual items - - (11.0)‡ (7.0)‡ (835.0)‡ (313.0)‡ (272.0)‡
EBT excl. unusual items (1,016.0)‡ 2,925.0‡ 2,648.0‡ 2,197.0‡ 2,250.0‡ 2,312.0‡ 2,578.0‡
EBT incl. unusual items (1,016.0) 2,925.0 2,637.0 2,190.0 1,415.0 1,999.0 2,306.0‡
Income tax expense (137.0) 847.0 573.0 526.0 385.0 529.0 616.0‡
Earnings from continuing operations (879.0)‡ 2,078.0‡ 2,064.0‡ 1,664.0‡ 1,030.0‡ 1,470.0‡ 1,690.0‡
Net income (879.0) 2,078.0 2,064.0 1,664.0 1,030.0 1,470.0 1,690.0‡
NI to common incl. extra items (879.0)‡ 2,078.0‡ 2,064.0‡ 1,664.0‡ 1,030.0‡ 1,470.0‡ 1,690.0‡
NI to common excl. extra items (879.0)‡ 2,078.0‡ 2,064.0‡ 1,664.0‡ 1,030.0‡ 1,470.0‡ 1,690.0‡
Revenue per share - 8.77‡ 8.71‡ 8.37‡ 8.07‡ 7.89‡ 8.09‡
Basic EPS - 1.21 1.20 0.90 0.54 0.77 0.88‡
Basic weighted average shares - 1,716.2 1,716.0 1,846.0 1,915.0 1,917.0 1,918.5‡
Diluted EPS - 1.21 1.20 0.90 0.54 0.76 0.88‡
Diluted weighted average shares - 1,716.2 1,716.0 1,850.0 1,923.0 1,924.0 1,922.5‡
Normalized net income (S&P method, 37.5 %) (635.0)‡ 1,828.1‡ 1,655.0‡ 1,373.1‡ 1,406.3‡ 1,445.0‡ 1,611.3‡
Normalized basic EPS (S&P method) - 1.07‡ 0.96‡ 0.74‡ 0.73‡ 0.75‡ 0.84‡
Normalized diluted EPS (S&P method) - 1.07‡ 0.96‡ 0.74‡ 0.73‡ 0.75‡ 0.84‡
EBITDA (233.0)‡ 3,651.0‡ 3,319.0‡ 3,139.0‡ 2,463.0‡ 2,971.0‡ 3,276.0‡
EBIT (979.0)‡ 2,920.0‡ 2,675.0‡ 2,512.0‡ 1,841.0‡ 2,414.0‡ 2,707.0‡
Effective tax rate NM 29.0%‡ 21.7%‡ 24.0%‡ 27.2%‡ 26.5%‡ 26.7%‡

‡ derived by arithmetic from reported figures (a fourth quarter is the year less nine months). † read from a substitute line. § reported in a note, not on the face of the statement. “-” not reported. NM not meaningful. Normalized rows follow the S&P method: pre-tax income excluding unusual items, a flat 37.5 % tax rate, less minority interest.

By business segment

Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025 TTM Sep 2026
Revenue
Essential Health 4,782.0 4,870.0 4,570.0 4,615.0 4,688.0 4,632.0 -
Self Care 5,235.0 5,643.0 6,030.0 6,451.0 6,527.0 6,378.0 -
Skin Health And Beauty 4,450.0 4,541.0 4,350.0 4,378.0 4,240.0 4,114.0 -

By geography

Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025 TTM Sep 2026
Revenue
Asia Pacific 3,013.0 3,276.0 3,146.0 3,107.0 2,974.0 2,775.0 -
EMEA 3,332.0 3,436.0 3,188.0 3,388.0 3,559.0 3,721.0 -
Latin America 1,027.0 1,058.0 1,198.0 1,339.0 1,343.0 1,369.0 -
North America 7,095.0 7,284.0 7,418.0 7,610.0 7,579.0 7,259.0 -
US 6,357.0 6,516.0 6,599.0 6,767.0 6,719.0 6,460.0 -

Segment figures as the company tagged them in its filings, one breakdown per table; members need not sum to the total.